Details About Generic Salt ::  Hydrocod

Main Medicine Class:: Narcotic analgesic   

(HIGH-droe-KOE-dohn by-TAR-trate/ass-eet-ah-MEE-noe-fen)
Anexsia 5/500, Anexsia 7.5/650, Anexsia 10/660, Bancap-HC, Ceta-Plus, Co-Gesic, Duocet, Dolacet, Duradyne DHC, Hydrocet, Hydrogesic, Hy-Phen, Lorcet 10/650, Lorcet-HD, Lorcet Plus, Lortab 5/500, Lortab 7.5/500, Lortab 10/500, Margesic H, Norco, Panacet 5/500, Stagesic, T-Gesic, Vicodin, Vicodin ES, Vicodin HP, Zydone
Class: Narcotic analgesic

 

Drugs Class ::

 Action Inhibits synthesis of prostaglandins and binds to opiate receptors in CNS and peripherally blocks pain impulse generation; produces antipyresis by direct action on hypothalamic heat-regulating center; causes cough suppression by direct central action in medulla; may produce generalized CNS depression.

Indications for Drugs ::

 Indications Management of mild-to-moderate pain.

Drug Dose ::

Route/Dosage

Varies according to product and strength. ADULTS: PO 1 to 2 tablets or capsules (hydrocodone 2.5 to 10 mg; acetaminophen 500 to 1000 mg) q 4 to 6 hr or 5 to 10 ml (elixir, 15 ml) q 4 to 6 hr prn. CHILDREN < 12 YR: PO 10 to 15 mg acetaminophen/kg/dose q 4 hr to maximum of 2.6 g/24 hr.

Contraindication ::

 Contraindications Hypersensitivity to acetaminophen, hydrocodone, or similar compounds.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and effectiveness in children have not been established. Special risk patients: Closely monitor elderly, debilitated patients, and those with conditions accompanied by hypoxia or hypercapnia to avoid decrease in pulmonary ventilation. Also use caution in patients sensitive to CNS depressants. Due to cough suppressant effects, exercise caution when using postoperatively or in patients with pulmonary disease. Hepatic impairment: Chronic alcoholics should limit acetaminophen intake to < 2 g/day. Sulfite sensitivity: Use caution in sulfite-sensitive individuals; some commercial preparations contain sodium bisulfite.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CV: Hypotension; bradycardia. CNS: Lightheadedness; dizziness; sedation; drowsiness; weakness; anxiety; fear; fatigue; dysphoria; psychological dependence; confusion. GI: Nausea; vomiting; constipation. GU: Decreased urination; urethral spasm. RESP: Dyspnea; respiratory depression; irregular breathing.

Drug Mode of Action ::  

 Action Inhibits synthesis of prostaglandins and binds to opiate receptors in CNS and peripherally blocks pain impulse generation; produces antipyresis by direct action on hypothalamic heat-regulating center; causes cough suppression by direct central action in medulla; may produce generalized CNS depression.

Drug Interactions ::

 Interactions

Anticholinergics: May produce paralytic ileus. Carbamazepine, hydantoins, sulfinpyrazone: May result in increased risk of hepatotoxicity from acetaminophen. CNS depressants (eg, barbiturates, ethyl alcohol, other narcotics): May cause CNS toxicity. MAO inhibitors: May cause additive CNS toxicity; may cause decreased BP. Tricyclic antidepressants, phenzothiazines: May cause additive CNS toxicity.

Drug Assesment ::

 Assessment/Interventions

  • Obtain complete patient history, including drug history and any known allergies.
  • Assess vital signs before and periodically after administration. If hypotension, bradycardia, bradypnea, or difficulty in breathing occurs, notify health care provider.
  • Monitor for orthostatic hypotension and supervise ambulation.
  • Encourage coughing and deep breathing in patients with pulmonary problems.
  • Monitor bowel and hepatic function. If decreased bowel sounds or abdominal distention, jaundice, or dark urine occurs, notify health care provider.
  • If confusion or blurred vision occur, institute safety measures and notify health care provider.
  • Check for reduced dosage if another CNS depressant medication is being administered concurrently.
OVERDOSAGE: SIGNS & SYMPTOMS
  Blood dyscrasias, respiratory depression, and hepatic necrosis (all may occur up to several days after overdose); renal tubular necrosis, hypoglycemic coma, nausea, vomiting, diaphoresis, malaise, somnolence, skeletal muscle flaccidity, bradycardia, hypotension, apnea, cardiac arrest

Drug Storage/Management ::

 Administration/Storage

  • Administer before pain becomes severe.
  • Give medication with food.
  • Store at room temperature and protect from light.

Drug Notes ::

 Patient/Family Education

  • Instruct patient to take before pain becomes severe.
  • Advise patient to take with food or milk.
  • When medication is being used for acute pain, advise patient of possible addiction and explain that drug should be used for short term only.
  • Advise patient to change position slowly and to use caution when ambulating and performing other activities requiring mental alertness such as driving or operating machinery.
  • Instruct patient to eat high-fiber diet, maintain adequate fluid intake, and use stool softener or bulk laxative to prevent constipation.
  • Advise patient to avoid alcohol and any other drug that causes drowsiness such as sleeping aids and antihistamines.
  • Instruct patient to discontinue drug and notify health care provider if blurred vision, rash, or yellowing of skin occurs.
  • If lightheadedness, dizziness, drowsiness, nausea, or vomiting occur, advise patient to lie down until symptoms subside and to notify health care provider if symptoms persist.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

We would like to keep you updated with special notifications.